Remove BMI Remove Circulation Remove Diabetes
article thumbnail

Abstract 4115222: Distinct Demographic, Cognitive, and Psychosocial Factors Associated with Different Types of Self-Care in Patients with Type 1 Diabetes and in Patients with Type 2 Diabetes

Circulation

Circulation, Volume 150, Issue Suppl_1 , Page A4115222-A4115222, November 12, 2024. Background:Poor self-care in patients with type 1 diabetes (T1DM) and type 2 diabetes (T2DM) leads to increased diabetes complications and health costs. 003), lower body mass index (BMI) (p =.040), 302), while lower BMI (p =.045)

article thumbnail

How Apob & Visceral Fat Increase Your Risk Of Heart Disease.

Dr. Paddy Barrett

When it comes to cardiovascular disease, two of the biggest risk factors we must consider are: ApoB concentration - A measure of the number of circulating lipid particles. Not all circulating ApoB particles will transition across the artery wall, but some will. Relationship of BMI and Risk Of Diabetes.

article thumbnail

Expert Perspective: The Obesity Paradox with Salvatore Carbone, PhD

Cardiometabolic Health Congress

There are significant data that show that if you have obesity, you have a high risk of developing coronary heart disease, heart failure, type 2 diabetes (T2D) or risk factors such as hypertension and dyslipidemia. [1] These individuals tend to have a better prognosis when compared to both individuals with normal weight (BMI of 18.5

Obesity 52
article thumbnail

Abstract 4142589: GLP-1 receptor agonists slow the progression of subclinical cardiovascular risk as detected from 12-lead electrocardiograms

Circulation

Circulation, Volume 150, Issue Suppl_1 , Page A4142589-A4142589, November 12, 2024. Background:GLP-1 receptor agonists (GLP1RA) agonists have been shown to reduce cardiovascular events in patients with type 2 diabetes (T2D) and atherosclerotic cardiovascular disease (ASCVD). Hispanic, 9.6% Asian, and 4.6% Hispanic, 9.6% Asian, and 4.6%

article thumbnail

Abstract 4148106: Hemophilia and Cardiovascular disease in the United States: Prevalence, Risk factors, and outcomes.

Circulation

Circulation, Volume 150, Issue Suppl_1 , Page A4148106-A4148106, November 12, 2024. 17.4]) and was also more likely to have diabetes mellitus, hyperlipidemia, chronic lung disease, chronic kidney disease, chronic liver disease, BMI ≥ 25, anemia, metastatic cancer, and atrial fibrillation.

article thumbnail

Abstract 4123899: Stroke Risk in Patients with an Isolated Interventricular Membranous Septal Aneurysm

Circulation

Circulation, Volume 150, Issue Suppl_1 , Page A4123899-A4123899, November 12, 2024. The mean BMI was 27.9 One patient had diabetes, 8 had hyperlipidemia, and 9 had hypertension. Of these, 9 (64%) were female with a mean age of 59.6, and 5 (36%) were male with a mean age of 55.4. kg/m2, with 4 classified as obese.

article thumbnail

FDA Approves Wegovy for Cardiovascular Risk Reduction in Adults with Known Heart Disease and Overweight or Obesity

DAIC

mg or placebo to cardiovascular standard of care in adults with overweight and obesity with established CVD and without diabetes. director of the Division of Diabetes, Lipid Disorders, and Obesity in the FDA’s Center for Drug Evaluation and Research , in a statement issued by the FDA. 2 Wegovy 2.4 with placebo. mg and 36.4%

Obesity 111